How should clinicians prescribe opioids for cancer-related pain in patients who use cocaine or methamphetamines?

Experts say to continue opioids and increase monitoring.

2023-09-11

(Press-News.org) Clinicians treating cancer-related pain must consider whether and how to prescribe opioids to patients who use nonmedical stimulants such as cocaine and methamphetamines; however, no guidelines exist related to these common and challenging situations. In a new study, palliative care and addiction experts deemed it appropriate to continue opioids, increase monitoring, and avoid opioid tapering in such patients. The results are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.

Using opioids and nonmedical stimulants together may increase the risk of various harms, including overdose and death. These harms may be especially pronounced in people with cancer, who may have compromised health and take multiple other medications.

To provide guidance on opioid management strategies for people with advanced cancer who use methamphetamines or cocaine, researchers recruited 120 palliative care and addiction experts and asked them to consider two different scenarios. In the first, a patient’s prognosis was weeks to months, and in the second, the prognosis was months to years. Experts reviewed, rated, and commented on the cases. They used a scale from 1 (very inappropriate) to 9 (very appropriate) to rate their opinions about different care-related actions, and they explained their responses.

The experts agreed that regardless of prognosis, clinicians should increase monitoring and continue opioids, without tapering. Such management strategies prioritize pain control and allow clinicians time to develop individualized harm-reduction approaches and refer to addiction specialists when appropriate. The use of buprenorphine/naloxone (an opioid medication that has a lower risk for overdose) was considered potentially appropriate in people with a longer prognosis, but inappropriate in people with a shorter prognosis. The experts noted that strategies aimed at reducing harms include frequent visits and patient education about the impurity and high potency of stimulant supplies, which often include illicit fentanyl.

“The study findings provide consensus-based guidance for clinicians who treat cancer-related pain and encounter stimulant use, and include management strategies they can bring immediately to their practice,” said lead author Dr. Katie Fitzgerald Jones of the VA Boston Healthcare System. “The results highlight a need for integrated care models to address substance use during cancer and create a research agenda that prioritizes substance use disorder as an important comorbidity in people with cancer.”

Additional information
NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. A free abstract of this article will be available via the CANCER Newsroom upon online publication. For more information or to obtain a PDF of any study, please contact: Sara Henning-Stout, newsroom@wiley.com

Full Citation:
“Expert consensus-based guidance on approaches to opioid management in individuals with advanced cancer-related pain and non-medical stimulant use.” Katie Fitzgerald Jones, Dmitry Khodyakov, Benjamin H. Han, Robert M. Arnold, Emily Dao, Jeni Morrison, Jennifer Kapo, Diane E. Meier, Judith A. Paice, Jane M. Liebschutz, Christine S. Ritchie, Jessica S. Merlin, and Hailey W. Bulls. CANCER; Published Online: September 11, 2023 (DOI: 10.1002/cncr.34921).

URL Upon Publication: http://doi.wiley.com/10.1002/cncr.34921

Author Contact: Winfield Danielson, Winfield.DanielsonIII@va.gov

About the Journal    
CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online. Follow CANCER on Twitter @JournalCancer and Instagram @ACSJournalCancer, and stay up to date with the American Cancer Society Journals on LinkedIn.

About Wiley
Wiley is a knowledge company and a global leader in research, publishing, and knowledge solutions. Dedicated to the creation and application of knowledge, Wiley serves the world’s researchers, learners, innovators, and leaders, helping them achieve their goals and solve the world's most important challenges. For more than two centuries, Wiley has been delivering on its timeless mission to unlock human potential. Visit us at Wiley.com. Follow us on Facebook, Twitter, LinkedIn and Instagram.

END

ELSE PRESS RELEASES FROM THIS DATE:

Sorghum bran packs bigger punch than whole grain

2023-09-11

Sorghum bran has much higher levels of some essential amino acids and minerals needed for human health and development than a whole grain or dehulled sorghum flour, researchers from the University of Johannesburg have found. Sorghum bran packs a calcium, magnesium, leucine and valine punch much higher than the whole grain flour. The climate-resilient gluten-free grain also holds its own on macro – and micronutrients compared to the biggest grains produced worldwide. Dr Janet Adebo and Dr Hema Kesa investigated and compared the nutritional quality and functional properties of the different ...

Study on consistency of greenhouse gas concentrations between GOSAT and GOSAT-2

2023-09-11

1.Background and objectives The Ministry of the Environment of Japan, the National Institute for Environmental Studies (NIES), and the Japan Aerospace Exploration Agency are jointly promoting the GOSAT series, a series of Earth observation satellites whose main purpose is to observe greenhouse gases from space; the Greenhouse gases Observing SATellite (GOSAT) launched in January 2009 and GOSAT-2 launched in October 2018 are currently in operation, and the Global Observing SATellite for Greenhouse gases and Water cycle (GOSAT-GW) is planned to be launched in Japan’s FY2024. NIES is responsible for developing ...

Hospital admissions for COPD increased substantially, especially in women and younger people

2023-09-11

Annual hospital admissions for chronic obstructive pulmonary disease (COPD) in Canada increased 69% since 2002, especially in females and people under age 65, according to new research in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.221051. COPD affects the lungs and progresses, resulting in frequent hospitalization, burdening patients, families and health care systems. It has been viewed as a condition usually associated with male smokers. "With increasing ...

Waterloo researchers make a significant step towards reliably processing quantum information

2023-09-11

Using laser light, researchers have developed the most robust method currently known to control individual qubits made of the chemical element barium. The ability to reliably control a qubit is an important achievement for realizing future functional quantum computers. This new method, developed at the University of Waterloo’s Institute for Quantum Computing (IQC), uses a small glass waveguide to separate laser beams and focus them four microns apart, about four-hundredths of the width of a single human hair. The precision and extent to which each focused laser beam on its target qubit can be controlled in parallel ...

FLAURA2 results demonstrate osimertinib plus chemotherapy superior compared to osimertinib alone

2023-09-11

(Singapore – 10:05 a.m. SGT--September 11, 2023) – Osimertinib plus chemotherapy demonstrated a statistically significant and clinically meaningful progression-free survival benefit compared to osimertinib alone, according to research presented today at the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer in Singapore. The FLAURA2 study was led by Dr. Pasi A. Jänne from the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute in Boston, Mass. Osimertinib, a potent third-generation EGFR-TKI with central nervous system activity, has garnered attention for its targeted ...

MARS trial: decortication and chemotherapy associated with worse outcomes for patients with resectable mesothelioma

2023-09-11

(Singapore, September 11, 2023, 10:05 a.m. SGT) – Extended pleurectomy decortication combined with chemotherapy is associated with worse survival outcomes, a higher incidence of serious adverse events, and a diminished quality of life compared to platinum and pemetrexed chemotherapy alone, according to research presented today the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer in Singapore. The UK Multicentre Randomised Trial, known as MARS 2, conducted by a team led by Professor Eric ...

Large-scale investigation supports modified classification system for pulmonary adenocarcinomas

2023-09-11

(Singapore – 10:05 a.m. SGT--September 11, 2023) – A modified adenocarcinoma classification approach significantly enhances reproducibility and may be an improvement on the existing World Health Organization classification system, according to research unveiled at the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer in Singapore. The study, led by Dr. Erik Thunnissen, Department of Pathology, Amsterdam UMC, VU Medical Center, Amsterdam, The Netherlands, ...

Taiwan launches National Lung Cancer Early Detection Program detects 85 percent of lung cancer cases at early phase

2023-09-11

First-ever National Screening Program to Consider Family History (Singapore – 10:05 a.m. SGT--September 11, 2023) – The Taiwan National Lung Cancer Early Detection Program detected 85 percent of lung cancer cases at either a phase 0 or phase 1 level, demonstrating that lung cancer screening can detect lung cancer at an early enough phase to allow doctors to intervene more effectively. The results of the program were presented by Pan-Chyr Yang, MD, PhD from the National Taiwan University Hospital, at the International Association for the Study of Lung Cancer 2023 World Conference ...

Surgical outcomes of perioperative durvalumab in AEGEAN study to be presented at IASLC 2023 World Conference on Lung Cancer

2023-09-11

[Singapore, 10:05 a.m. SGT--September 11, 2023] – Adding perioperative durvalumab to neoadjuvant chemotherapy did not adversely impact surgery in patients with resectable NSCLC and was associated with a tolerable surgical safety profile, according to research presented today from the phase 3 AEGEAN trial at the International Association for the Study of Lung Cancer 2023 World Conference on Lung Cancer in Singapore. "The AEGEAN trial demonstrated a clinically meaningful improvement in EFS ...

Treatment for dangerous snoring prevents deaths from heart disease

2023-09-11

Milan, Italy: People suffering with obstructive sleep apnoea (OSA) can reduce their risk of dying from cardiovascular disease if they use a continuous positive airway pressure (CPAP) machine at night, according to research presented at the European Respiratory Society International Congress in Milan, Italy [1]. CPAP may also work better than a weight loss drug in reducing the build-up of plaque in the arteries around the heart, according to a pilot study also presented at the European Respiratory Society International Congress [2]. People with OSA often snore loudly, their breathing starts and stops during the night, and they may ...

How should clinicians prescribe opioids for cancer-related pain in patients who use cocaine or methamphetamines?

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: